ZIP Proteins and Iron Metabolism
ZIP 蛋白质和铁代谢
基本信息
- 批准号:7884238
- 负责人:
- 金额:$ 27.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeApplications GrantsApplied GeneticsBacteriaBindingBiological ProcessCell Culture TechniquesCell membraneCellsCollaborationsDNADataDependenceDepositionDietDietary IronDioxygenDiseaseDrug or chemical Tissue DistributionElectron TransportFamilyFamily memberGenesHealthHemochromatosisHepaticHomeostasisHumanHuman bodyIndividualIntegral Membrane ProteinIntestinesIonsIronIron Metabolism DisordersIron OverloadKnock-outKnockout MiceKnowledgeLaboratoriesLeadLipidsLiverMeasuresMediatingMetabolismMetalsMolecularMorbidity - disease rateMusMutateNatureNutrientOrganismOxidation-ReductionPathway interactionsPhysiologicalPlayPrevalencePropertyProteinsPublic HealthRadiolabeledRattusReactionReactive Oxygen SpeciesRegulationRelative (related person)ResearchRoleTechniquesTestingTissuesTransfectionTransferrinTransition ElementsUp-RegulationVenous blood samplingWomanWorkZIP proteinZincbasecell typehazardin vivoiron metabolismmembermortalitynoveloverexpressionoxidationprotein transportradiotracerreproductiveresearch studytherapeutic targettraffickinguptakezinc-binding protein
项目摘要
DESCRIPTION (provided by applicant): Disturbances of iron metabolism increase morbidity and mortality and are among the most common disorders affecting humans. Nearly 20% of women of reproductive age in the US are iron deficient, and iron overload is increasingly being recognized as a public health concern. Despite the prevalence and adverse health effects associated with these disorders, many questions remain regarding the molecular mechanisms of iron transport. The long-term objective of the proposed work is to enhance our understanding of iron homeostasis by investigating the regulation and function of ZIP14 and other ZIP family members. ZIP14 was first identified as a zinc transporter, but recent studies indicate that it transports iron as well. Its abundant expression in the liver suggests that it plays a role in hepatic iron deposition during iron overload, and its upregulation in liver by phlebotomy and iron deficiency suggests that it functions in iron uptake. The first aim of the proposed research will be to investigate more completely the iron-dependent regulation of Zip14. Rats and mice will be made iron deficient, iron normal, or iron loaded, and a variety of tissues will be examined for Zip14 expression and cellular localization. In the second aim, cell culture studies will be used to identify the subcellular localization of Zip14 and to investigate its role in the uptake of transferrin-bound iron, the most common pathway of iron uptake by cells. To better define the in vivo role of Zip14, the third aim will characterize the iron status of Zip14 knockout mice. Tissue-specific knockout mice will be used to test the hypotheses that Zip14 plays a role in the uptake of non-transferrin-bound iron by the liver and dietary iron by the intestine. In the fourth aim, the iron transport activity of all mammalian ZIP proteins will be systematically assessed by overexpressing the proteins and measuring the uptake of radiolabeled iron. We will also examine the effect of in vivo iron status on the expression of all 14 ZIP family members. We anticipate that information derived from the experiments with Zip14, and perhaps other ZIP proteins, will be relevant to disorders of iron metabolism. Identification of other ZIP proteins that are capable of transporting iron or are regulated by iron status will enhance our basic understanding of iron homeostasis and metal ion trafficking in general. Disturbances of iron metabolism increase morbidity and mortality and are among the most common disorders affecting humans. Despite the prevalence and adverse health effects associated with these disorders, many questions remain regarding the molecular mechanisms of iron transport. The research described in this proposal will enhance our knowledge of iron transport, which will ultimately help to identify therapeutic targets for treating disorders of iron metabolism. PUBLIC HEALTH RELEVANCE: Disturbances of iron metabolism increase morbidity and mortality and are among the most common disorders affecting humans. Despite the prevalence and adverse health effects associated with these disorders, many questions remain regarding the molecular mechanisms of iron transport. The research described in this proposal will enhance our knowledge of iron transport, which will ultimately help to identify therapeutic targets for treating disorders of iron metabolism.
描述(由申请人提供):铁代谢紊乱会增加发病率和死亡率,是影响人类的最常见疾病之一。美国近 20% 的育龄妇女缺铁,铁超载日益被视为一个公共健康问题。尽管这些疾病普遍存在并且对健康产生不利影响,但关于铁转运的分子机制仍然存在许多问题。拟议工作的长期目标是通过研究 ZIP14 和其他 ZIP 家族成员的调节和功能来增强我们对铁稳态的理解。 ZIP14 最初被确定为锌转运蛋白,但最近的研究表明它也转运铁。它在肝脏中的丰富表达表明它在铁超载期间在肝脏铁沉积中发挥作用,而放血和缺铁时它在肝脏中的上调表明它在铁吸收中发挥作用。本研究的首要目标是更全面地研究 Zip14 的铁依赖性调节。大鼠和小鼠将被制成缺铁、正常铁或铁负荷状态,并检查各种组织的 Zip14 表达和细胞定位。第二个目标是,细胞培养研究将用于鉴定 Zip14 的亚细胞定位,并研究其在转铁蛋白结合铁的摄取中的作用,转铁蛋白结合的铁是细胞摄取铁的最常见途径。为了更好地确定 Zip14 的体内作用,第三个目标将表征 Zip14 敲除小鼠的铁状态。组织特异性敲除小鼠将用于测试 Zip14 在肝脏吸收非转铁蛋白结合铁和肠道吸收膳食铁中发挥作用的假设。第四个目标是通过过表达蛋白质并测量放射性标记铁的吸收来系统评估所有哺乳动物 ZIP 蛋白的铁转运活性。我们还将研究体内铁状态对所有 14 个 ZIP 家族成员表达的影响。我们预计从 Zip14 以及其他 ZIP 蛋白实验中获得的信息将与铁代谢紊乱相关。鉴定其他能够运输铁或受铁状态调节的 ZIP 蛋白将增强我们对铁稳态和金属离子运输的基本了解。铁代谢紊乱会增加发病率和死亡率,是影响人类的最常见疾病之一。尽管这些疾病普遍存在并且对健康产生不利影响,但关于铁转运的分子机制仍然存在许多问题。该提案中描述的研究将增强我们对铁转运的了解,这最终将有助于确定治疗铁代谢紊乱的治疗靶点。公共卫生相关性:铁代谢紊乱会增加发病率和死亡率,是影响人类的最常见疾病之一。尽管这些疾病普遍存在并且对健康产生不利影响,但关于铁转运的分子机制仍然存在许多问题。该提案中描述的研究将增强我们对铁转运的了解,这最终将有助于确定治疗铁代谢紊乱的治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mitchell D Knutson其他文献
The elusive endothelial iron transporter.
难以捉摸的内皮铁转运蛋白。
- DOI:
10.1182/blood.2024024664 - 发表时间:
2024-06-06 - 期刊:
- 影响因子:20.3
- 作者:
Mitchell D Knutson - 通讯作者:
Mitchell D Knutson
Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages.
铁负荷和红细胞吞噬作用会增加 J774 巨噬细胞中铁转运蛋白 1 (FPN1) 的表达。
- DOI:
10.1182/blood-2003-04-1250 - 发表时间:
2003-12-01 - 期刊:
- 影响因子:20.3
- 作者:
Mitchell D Knutson;Mohammad R Vafa;David J Haile;Marianne Wessling - 通讯作者:
Marianne Wessling
Mitchell D Knutson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mitchell D Knutson', 18)}}的其他基金
FASEB SRC: The Trace Elements in Biology and Medicine Conference
FASEB SRC:生物学和医学中的微量元素会议
- 批准号:
10469205 - 财政年份:2022
- 资助金额:
$ 27.47万 - 项目类别:
相似国自然基金
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GNAS介导OPN4-PLCβ4-TRPC6/7通路调节自主感光视网膜神经节细胞在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301229
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Assessing the Impact of Age, Sex, and Menopause on Scleral Biomechanics and Gene Expression
评估年龄、性别和更年期对巩膜生物力学和基因表达的影响
- 批准号:
10726826 - 财政年份:2023
- 资助金额:
$ 27.47万 - 项目类别:
Ion Mobility Spectrometry- quadrupole Time-of-Flight (IMS-qToF) Mass Spectrometer
离子淌度光谱仪 - 四极杆飞行时间 (IMS-qToF) 质谱仪
- 批准号:
10630627 - 财政年份:2023
- 资助金额:
$ 27.47万 - 项目类别:
Mechanisms of Trypsin Activation in Pancreatitis
胰腺炎中胰蛋白酶激活的机制
- 批准号:
10587286 - 财政年份:2023
- 资助金额:
$ 27.47万 - 项目类别:
Delineating the role of the gut microbiota and its derived metabolites in the development of dementia in multi-ethnic populations
描述肠道微生物群及其衍生代谢物在多种族人群痴呆症发展中的作用
- 批准号:
10592025 - 财政年份:2023
- 资助金额:
$ 27.47万 - 项目类别:
Leveraging Molecular Technologies to Improve Diagnosis and Management of Pediatric Acute Respiratory Illness in Resource-Constrained Settings
利用分子技术改善资源有限环境中儿科急性呼吸系统疾病的诊断和管理
- 批准号:
10739603 - 财政年份:2023
- 资助金额:
$ 27.47万 - 项目类别: